Drugs / AMARGOL®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01485328 Comparator | Dec 2008 → Apr 2009 | digestive system disorder | Laboratorio Saude Ltda. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMARGOL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01485328 ↗ |
| Route | Oral | “per oral solution, 40 mL single dose” NCT01485328 ↗ |